Journals / Türk Kardiyoloji Derneği Arşivi
Türk Kardiyoloji Derneği ArşiviFen
2016 · Cilt: 44 - Sayı: Suppl. 2
| Article | Author | Pages |
|---|---|---|
| Clinical pharmacology of the apixaban and frequently asked questions about its clinical use | Adnan ABACI | 1–6 |
| Protection in atrial fibrillation | Lale TOKGÖZOĞLU, Bülent GÖRENEK | 7–13 |
| ARISTOTLE study and sub-group analyses: Conspicuous points | Özgür ASLAN | 14–25 |
| The use of new oral anticoagulants in atrial fibrillation patients unsuitable for warfarin therapy | Mesut DEMİR | 26–32 |
| Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies? | Necla ÖZER | 33–40 |
| Venous thromboembolism studies of apixaban and its clinical use | A. Kürşat BOZKURT | 41–46 |